In addition, urine TMPRSS2-ERG levels seem to be associated with indicators of clinically significant prostate cancer at biopsy and prostatectomy such as Gleason score, the percent of tumor observed, and number of cores with tumor. This evidence concerns the gene TMPRSS2 and prostate carcinoma.